Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Steve Stuart who wrote (9269)	5/11/1998 10:59:00 AM
From: Scott H. Davis	Respond to of 14328

Steve, I wonder if the settlement news is quietly going out. TRIBY's up (2 13/32 x 2 7/16) on good volume as of 10:40. The SLF qtr report was also bullish in that in addition to significantly less loss, the CEO comments were bullish: <Ron Zwanziger, Chief Executive Officer of Selfcare, Inc., commented, ''For the first time in our history all segments of the Selfcare business contributed to the Company's progress. This quarter marked the eighth consecutive quarter of increased product revenue. In addition, the Company showed consistent operational improvements.'' Mr. Zwanziger continued, ''We made significant strides in our diabetes area, which was due both to an accretive performance from our Can-Am Care Corporation acquisition announced in February and the Inverness, Scotland operation. We continue to be optimistic in our outlook for the remainder of the year.'' May partially be that the biotech sector seems to be doing well last few days - the recent cancer releases & articles have sparked interest in the sector. FYI, Scott (not always bearish)

To: Steve Stuart who wrote (9269)	5/11/1998 11:11:00 AM
From: Ray	Read Replies (1) \| Respond to of 14328

Triby owns almost 800,000 shares -- 799,622 to be exact. See below -- from the April proxy statement from SLF. Ray ACCESSION NUMBER: 0000950135-98-002554 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19980528 FILED AS OF DATE: 19980422 SROS: AMEX FILER: COMPANY DATA: COMPANY CONFORMED NAME: SELFCARE INC CENTRAL INDEX KEY: 0000915901 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 043164127 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 NAME AND ADDRESS AMOUNT AND OF NATURE OF PERCENT BENEFICIAL OWNER(1) BENEFICIAL OWNER(2) OF CLASS ------------------- ------------------- -------- 5% STOCKHOLDERS Trinity Biotech plc(3)...................................... 799,622 8.2% 3 Roch Road Sandyford Industrial Estates Dublin 18, Ireland (3) Trinity Biotech plc ("Trinity") and Eastcourt Limited ("Eastcourt") have filed Schedule 13Ds with the Securities and Exchange Commission (the "Commission") stating that Enviromed plc sold the Company's Common Stock held of record by Enviromed to Flambelle Limited ("Flambelle"), a wholly-owned subsidiary of Trinity, and Eastcourt, an entity owned 50% each by Enviromed and Flambelle, on August 28, 1996. On November 1, 1996, Enviromed announced that it had disposed of its shares of Eastcourt to Flambelle for consideration of $1.25 million. In December 1996, Eastcourt filed a Schedule 13D/A and Trinity and Flambelle filed a joint Schedule 13D with the Commission. On February 12, 1997, Flambelle and Eastcourt commenced a lawsuit against the Company in the United States District Court for the District of Massachusetts, seeking a declaratory judgment that Flambelle and Eastcourt own the Common Stock held of record by Enviromed plc and damages for alleged breach of a registration rights agreement. As of March 6, 1998, the Company entered into a settlement agreement with Trinity and Flambelle whereby the parties agreed that Flambelle shall have title to 80% of the shares of Selfcare stock in dispute, amounting to 622,898 shares of the Company's Common Stock, and Selfcare shall have title to the remaining 20% of said shares, amounting to 155,724 shares of its Common Stock. Replacement stock certificates have been issued and the lawsuit has been dismissed 2 6 with prejudice. The Company believes, based solely upon the information provided in the Schedule 13Ds filed jointly by Trinity and Flambelle and by Eastcourt, that Flambelle is incorporated under the laws of the Republic of Ireland and is a direct wholly-owned subsidiary of Trinity, an entity incorporated under the laws of the Republic of Ireland, and Eastcourt is incorporated under the laws of England and Wales and is a direct wholly-owned subsidiary of Flambelle. The Company further believes, based solely upon the information provided in the Schedule 13D filed by Flambelle, that Ronan O'Caoimh is the President and sole director of Flambelle and that the following are the executive officers and directors of Trinity: Mr. O'Caoimh, Chairman and Chief Executive Officer; Denis Burger, a non-executive Director; Brendan Farrell, the President and Director; Jonathan O'Connell, the Chief Financial Officer and a Director; and James Walsh, the Chief Operating Officer and Director. The Company further believes, based solely on the Schedule 13Ds filed by Eastcourt, that Mr. O'Caoimh is the President and sole director of Eastcourt.